| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 23, 2004
From the Departments of Radiology and Radiological Sciences (V.B.H., M.N.H.) and Pediatrics (T.R.B.), Uniformed Services University of the Health Sciences, Bethesda, Md; Diagnostic Radiology Department (V.B.H., M.N.H.), Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Md; and Developmental Endocrinology Branch (V.K.B., M.C., P.L.V., C.A.B.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md. * To whom correspondence should be addressed. E-mail: vho{at}usuhs.mil.
Background--Turner syndrome (TS) is associated with aortic coarctation and dissection; hence, echocardiographic evaluation of all patients is currently recommended. X-ray angiography in clinically symptomatic patients has suggested a range of other vascular anomalies, but the true prevalence of such lesions in TS is unknown. To better understand the prevalence and pathogenesis of cardiovascular defects in TS, we prospectively evaluated a group of asymptomatic adult volunteers with TS using magnetic resonance (MR) angiography. Methods and Results--A total of 85 adults with TS and 27 normal female adult volunteers underwent gadolinium-enhanced 3D MR angiography. A high prevalence of aortic anomalies was seen in women with TS, including elongation of the transverse arch (49%), aortic coarctation (12%), and aberrant right subclavian artery (8%). Venous anomalies were also prominent, including persistent left superior vena cava (13%) and partial anomalous pulmonary venous return (13%). None of these anomalies were found in healthy female controls. The constellation of elongation of the transverse arch, aortic coarctation, and persistent left superior vena cava was significantly associated with women with TS. Neck webbing and increased thoracic anterior-to-posterior dimension diameters were strong predictors for arterial and venous anomalies. Conclusions--Thoracic vascular anomalies are common in TS, occurring in
Revised on April 19, 2004
Accepted on June 22, 2004
Major Vascular Anomalies in Turner Syndrome. Prevalence and Magnetic Resonance Angiographic Features
Vincent B. Ho MD*,
50% of a group not preselected for cardiovascular disease. The highly significant association between neck webbing, increased chest diameter, and these vascular anomalies suggests that in utero, centrally localized lymphatic obstruction may contribute to these cardiovascular deformities in TS. Improved recognition of these often-undetected vascular lesions may be important for identification of patients in need of closer cardiovascular monitoring.
This article has been cited by other articles:
![]() |
A. O. Caglayan and M. Dundar Inherited diseases and syndromes leading to aortic aneurysms and dissections Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 931 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Hjerrild, K. H. Mortensen, and C. H. Gravholt Turner syndrome and clinical treatment Br. Med. Bull., June 1, 2008; 86(1): 77 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sachdev, L. A. Matura, S. Sidenko, V. B. Ho, A. E. Arai, D. R. Rosing, and C. A. Bondy Aortic Valve Disease in Turner Syndrome J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1904 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Matura, V. B. Ho, D. R. Rosing, and C. A. Bondy Aortic Dilatation and Dissection in Turner Syndrome Circulation, October 9, 2007; 116(15): 1663 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Gravholt, B. E. Hjerrild, L. Mosekilde, T. K. Hansen, L. M. Rasmussen, J. Frystyk, A. Flyvbjerg, and J. S. Christiansen Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur. J. Endocrinol., October 1, 2006; 155(4): 583 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stochholm, S. Juul, K. Juel, R. W. Naeraa, and C. Hojbjerg Gravholt Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3897 - 3902. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bondy, I. Ceniceros, P. L. Van, V. K. Bakalov, and D. R. Rosing Prolonged Rate-Corrected QT Interval and Other Electrocardiogram Abnormalities in Girls With Turner Syndrome Pediatrics, October 1, 2006; 118(4): e1220 - e1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ostberg, A. E. Donald, J. P. J. Halcox, C. Storry, C. McCarthy, and G. S. Conway Vasculopathy in Turner Syndrome: Arterial Dilatation and Intimal Thickening without Endothelial Dysfunction J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5161 - 5166. [Abstract] [Full Text] [PDF] |
||||
![]() |
Enhanced MRA Defines Vascular Anomalies in Turner Syndrome Journal Watch Women's Health, November 23, 2004; 2004(1123): 4 - 4. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |